Spanish biotech SpliceBio has raised $135 million in financing that will help it move a gene-editing therapy for an inherited retinal disease (IRD) through clinical testing. SpliceBio's lead in-house ...
Alternative splicing is a process that enables a messenger RNA (mRNA) to direct synthesis of different protein variants (isoforms) that may have different cellular functions or properties. It occurs ...
The patent covers devices comprising arrays of single molecules, including polynucleotides; methods for producing the devices; and their subsequent use. with the Breaking Science News daily newsletter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results